{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:13:35Z","timestamp":1780085615343,"version":"3.54.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Medical University of Lublin, Poland","award":["DS 324\/2016"],"award-info":[{"award-number":["DS 324\/2016"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejphar.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T18:15:36Z","timestamp":1499710536000},"page":"216-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["SN003, a CRF 1 receptor antagonist, attenuates depressive-like behavior and detrusor overactivity symptoms induced by 13- cis -retinoic acid in rats"],"prefix":"10.1016","volume":"812","author":[{"given":"Andrzej","family":"Wr\u00f3bel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Doboszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Rechberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Rechberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.07.010_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1464-410X.2006.06003.x","article-title":"Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes","volume":"97","author":"Angelico","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2017.07.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders","volume":"160","author":"Arborelius","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib3","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1523\/JNEUROSCI.23-12-05295.2003","article-title":"Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses","volume":"23","author":"Bale","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2017.07.010_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mp.2009.141","article-title":"The CRF system, stress, depression and anxiety-insights from human genetic studies","volume":"15","author":"Binder","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.07.010_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygcen.2005.11.014","article-title":"Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides","volume":"146","author":"Boorse","year":"2006","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00442247","article-title":"Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation","volume":"97","author":"Borsini","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2017.07.010_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbr.2014.05.035","article-title":"SSRI or CRF antagonism partially ameliorate depressive-like behavior after adolescent social defeat","volume":"270","author":"Bourke","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2017.07.010_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pnpbp.2007.07.001","article-title":"The neurobiology of retinoic acid in affective disorders","volume":"32","author":"Bremner","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.07.010_bib9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/GCO.0000000000000207","article-title":"New evidence in the treatment of overactive bladder","volume":"27","author":"Brown","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.12.054","article-title":"Chronic all-trans retinoic acid administration induces CRF over-expression accompanied by AVP up-regulation and multiple CRF-controlling receptors disturbance in the hypothalamus of rats","volume":"1601","author":"Cai","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2017.07.010_bib11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0024-3205(01)01182-1","article-title":"Effects of anesthesia on cystometry and leak point pressure of the female rat","volume":"69","author":"Cannon","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2017.07.010_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2003.11.032","article-title":"Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995\/CRA0450","volume":"485","author":"Chaki","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pnpbp.2012.07.019","article-title":"Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543","volume":"40","author":"Dournes","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.07.010_bib14","first-page":"71","article-title":"Review of the epidemiology of overactive bladder","volume":"8","author":"Eapen","year":"2016","journal-title":"Res. Rep. Urol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.12740\/PP\/OnlineFirst\/59162","article-title":"Lower urinary tract symptoms, nocturia and overactive bladder in patients with depression and anxiety","volume":"50","author":"Go\u0142\u0105bek","year":"2016","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib16","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/01.ju.0000177450.34451.97","article-title":"Brain control of normal and overactive bladder","volume":"174","author":"Griffiths","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JOE-13-0422","article-title":"Corticotropin-releasing factor family peptide signaling in feline bladder urothelial cells","volume":"222","author":"Hanna-Mitchell","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00210-012-0814-3","article-title":"Effect of mirabegron, a novel \u03b23-adrenoceptor agonist, on bladder function during storage phase in rats","volume":"386","author":"Hatanaka","year":"2013","journal-title":"Naunyn Schmiede. Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00192-011-1659-x","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint terminology and classification of the complications related to native tissue female pelvic floor surgery","volume":"23","author":"Haylen","year":"2012","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.ejphar.2017.07.010_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pbb.2006.12.021","article-title":"Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression","volume":"86","author":"Hodgson","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2017.07.010_bib21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1464-410X.2010.09993.x","article-title":"Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction","volume":"108","author":"Irwin","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2017.07.010_bib22","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/mp.2008.91","article-title":"Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes","volume":"14","author":"Keen-Rhinehart","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.07.010_bib24","first-page":"2069","article-title":"Pharmacology of 13-cis-retinoic acid in humans","volume":"42","author":"Kerr","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2017.07.010_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-0327(02)00426-3","article-title":"Epidemiology of women and depression","volume":"74","author":"Kessler","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2017.07.010_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jchemneu.2013.05.003","article-title":"CRH: the link between hormonal-, metabolic- and behavioral responses to stress","volume":"54","author":"Kov\u00e1cs","year":"2013","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ejphar.2017.07.010_bib27","doi-asserted-by":"crossref","first-page":"R692","DOI":"10.1152\/ajpregu.00086.2006","article-title":"Expression of corticotropin-releasing factor and CRF receptors in micturition pathways after cyclophosphamide-induced cystitis","volume":"291","author":"LaBerge","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib28","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/npp.2015.70","article-title":"Ketamine strengthens CRF-activated amygdala inputs to basal dendrites in mPFC layer V pyramidal cells in the prelimbic but not infralimbic subregion, a key suppressor of stress responses","volume":"40","author":"Liu","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2017.07.010_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(97)00025-3","article-title":"Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist","volume":"323","author":"Mansbach","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.comppsych.2007.06.012","article-title":"Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study","volume":"49","author":"Marcus","year":"2008","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.07.010_bib31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.biopsych.2007.10.016","article-title":"Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior","volume":"63","author":"Meloni","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.07.010_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/nau.23277","article-title":"Severe depression and anxiety in women with overactive bladder","author":"Melotti","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2017.07.010_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/aja.1001650404","article-title":"Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain","volume":"165","author":"Merchenthaler","year":"1982","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.ejphar.2017.07.010_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpurol.2016.08.030","article-title":"Assessment of serum level of corticotropin-releasing factor in primary nocturnal enuresis","volume":"13","author":"Motawie","year":"2017","journal-title":"J. Pediatr. Urol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib35","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.npp.1300998","article-title":"Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice","volume":"31","author":"O'Reilly","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2017.07.010_bib36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(24)38220-5","article-title":"Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001","volume":"289","author":"Okuyama","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.07.010_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2004.06.035","article-title":"Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression","volume":"497","author":"Overstreet","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib38","doi-asserted-by":"crossref","unstructured":"Owens, M.J., Nemeroff, C.B., 1993. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. In: Proceedings\u00a0of the Ciba Found. Symp., vol. 172, pp. 296\u2013308.","DOI":"10.1002\/9780470514368.ch15"},{"key":"10.1016\/j.ejphar.2017.07.010_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2011.12.002","article-title":"Effect of tramadol on pain-related behaviors and bladder overactivity in rodent cystitis models","volume":"676","author":"Oyama","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0304-3940(95)11873-U","article-title":"Central regulation of micturition in the rat the corticotropin-releasing hormone from Barrington's nucleus","volume":"196","author":"Pavcovich","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2017.07.010_bib41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2017.07.010_bib42","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1038\/tp.2014.25","article-title":"Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal","volume":"4","author":"Qi","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.07.010_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrurol.2012.33","article-title":"The role of prostanoids in urinary bladder physiology","volume":"9","author":"Rahnama'i","year":"2012","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib44","doi-asserted-by":"crossref","first-page":"e0121883","DOI":"10.1371\/journal.pone.0121883","article-title":"Serotonin and noradrenaline reuptake inhibitors improve micturition control in mice","volume":"10","author":"Redaelli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2017.07.010_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-1241.2007.01625.x","article-title":"Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions","volume":"62","author":"Staskin","year":"2008","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ejphar.2017.07.010_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2005.02.023","article-title":"Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats","volume":"512","author":"Suzuki","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrurol.2010.203","article-title":"The bladder-brain connection: putative role of corticotropin-releasing factor","volume":"8","author":"Valentino","year":"2011","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpsychores.2014.11.019","article-title":"Affective symptoms and the overactive bladder \u2013 a systematic review","volume":"78","author":"Vrijens","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.ejphar.2017.07.010_bib49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/mp.2008.38","article-title":"Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances","volume":"13","author":"Wang","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.07.010_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0090-4295(98)90009-7","article-title":"Pharmacologic options for the overactive bladder","volume":"51","author":"Wein","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2017.07.010_bib51","first-page":"731","article-title":"The effects of pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam on noxious stimulus perception in adult male rats","volume":"37","author":"Wixson","year":"1987","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.ejphar.2017.07.010_bib52","doi-asserted-by":"crossref","first-page":"R1671","DOI":"10.1152\/ajpregu.91013.2008","article-title":"Social stress-induced bladder dysfunction: potential role of corticotropin-releasing factor","volume":"296","author":"Wood","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib53","doi-asserted-by":"crossref","first-page":"R940","DOI":"10.1152\/ajpregu.00257.2012","article-title":"A corticotropin-releasing factor receptor antagonist improves urodynamic dysfunction produced by social stress or partial bladder outlet obstruction in male rats","volume":"304","author":"Wood","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2017.07.010_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vascn.2015.04.006","article-title":"A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation","volume":"74","author":"Wr\u00f3bel","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2017.07.010_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vascn.2016.04.001","article-title":"An animal model of detrusor overactivity induced by depression","volume":"80","author":"Wr\u00f3bel","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2017.07.010_bib56","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00192-016-3027-3","article-title":"Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms","volume":"27","author":"Wr\u00f3bel","year":"2016","journal-title":"Int. Urogynecol. J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917304569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917304569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:00:30Z","timestamp":1750536030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917304569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":56,"alternative-id":["S0014299917304569"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.010","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SN003, a CRF1 receptor antagonist, attenuates depressive-like behavior and detrusor overactivity symptoms induced by 13-cis-retinoic acid in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}